References
- Konstantinou K , DunnKM. Sciatica: review of epidemiological studies and prevalence estimates. Spine33(22) , 2464–2472 (2008).
- Weber H , HolmeI, AmlieE. The natural course of acute sciatica with nerve root symptoms in a double-blind placebo-controlled trial evaluating the effect of piroxicam. Spine18(11) , 1433–1438 (1993).
- Hagen KB , JamtvedtG, HildeG, WinnemMF. The updated Cochrane Review of bed rest for low back pain and sciatica. Spine30(5) , 542–546 (2005).
- Koes BW , van Tulder MW, Peul WC. Diagnosis and treatment of sciatica. BMJ334(7607) , 1313–1317 (2007).
- Weber H . Lumbar disc herniation. A controlled, prospective study with ten years of observation. Spine8(2) , 131–140 (1983).
- Gustorff B , DornerT, LikarR et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol. Scand. 52(1) , 132–136 (2008).
- Bachur NR , MasekK, MelmonKL, UdenfriendS. Fatty acid amides of ethanolamine in mammalian tissues. J. Biol. Chem.240 , 1019–1024 (1965).
- Devane WA , HanusL, BreuerA et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258(5090) , 1946–1949 (1992).
- Guida G , de Martino M, Cantieri L et al. La palmitoiletanolamida (Normast) en el dolor neuropático crónico por lumbociatalgia de tipo compresivo: estudio clínico multicéntrico. Dolor25(1) , 37–42 (2010).
- Bouhassira D , AttalN, AlchaarH et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114(1–2) , 29–36 (2005).
- Gandek B , WareJE, AaronsonNK et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 51(11) , 1171–1178 (1998).
- Fairbank JC , PynsentPB. The Oswestry Disability Index. Spine25(22) , 2940–2952 (2000).
- Ueda N , YamanakaK, YamamotoS. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J. Biol. Chem.276(38) , 35552–35557 (2001).
- Mazzari S , CanellaR, PetrelliL, MarcolongoG, LeonA. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol.300(3) , 227–236 (1996).
- Berdyshev EV , BoichotE, GermainN et al. Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol. 330(2–3) , 231–240 (1997).
- Calignano A , La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature394(6690) , 277–281 (1998).
- Skaper SD , BurianiA, Dal Toso R et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl Acad. Sci. USA93(9) , 3984–3989 (1996).
- Luo X , Lynn George M, Kakouras I et al. Reliability, validity, and responsiveness of the short form 12-item survey (SF-12) in patients with back pain. Spine28(15) , 1739–1745 (2003).
- Puhl AA , ReinhartCJ, RokER, InjeyanHS. An examination of the observed placebo effect associated with the treatment of low back pain – a systematic review. Pain Res. Manag.16(1) , 45–52 (2011).